Evaluation and Performance of StatStrip Glucose Meter. 1 These are factors known to affect the performance of glucose
|
|
- Daniella Palmer
- 7 years ago
- Views:
Transcription
1 ORIGINAL ARTICLE Evaluation and Performance of StatStrip Glucose Meter Megan Amelia Rensburg, MBChB, FC Path (SA), MMed (Chem Path), Careen Hudson, MBChB, FC Path (SA), MMed (Chem Path), and Rajiv Timothy Erasmus, MBBS, FMC Path (Nig), FWACP (W. Af), DABCC (Am Board Certified), DHSM (Natal), FC Path (SA) Abstract: Point-of-care testing glucose meter use is on the increase and is widely used in monitoring hospitalized patients as well as by patients for selfmonitoring. A major concern is the accuracy of glucose meters in different clinical settings. StatStrip (Nova Biomedical, Waltham, Mass) is a new generation glucose and quantitative ketone meter designed to correct for common biochemical interferences and to measure and correct hematocrit. Our aim was to assess the analytical performance of the StatStrip (Xpress and Connectivity) to Accu-Chek Active meters (Roche Diagnostics, Mannheim, Germany) and assess the glucose meters in a clinical setting. Hematocrit interference and chemical interferences (ascorbic acid, maltose, xylose, and acetaminophen) were evaluated at different glucose levels and different interferent concentrations. Whole blood samples collected from patients attending the medical outpatients department were measured and compared with the reference method (Siemens Advia glucose oxidase) and assessed by comparison with the ISO glucose performance criteria. Diabetic patients were included for this evaluation. Finger-prick (capillary) glucose (obtained from diabetic patients) measured on the glucose meters was compared with plasma glucose measured in the laboratory (Siemens Advia glucose oxidase). Minimal hematocrit and chemical interference were observed on the StatStrip meters, whereas the Accu-Chek Active meters were significantly affected by both abnormal hematocrit and chemical interference. StatStrip correlated best to the reference method and demonstrated the lowest bias. The StatStrip glucose meters demonstrated acceptable correlation when compared with the reference method, were not susceptible to common interferences observed on currently used glucose meters, and performed well in the clinical setting. Key Words: point-of-care testing, glucose meters, hematocrit, method validation (Point of Care 2014;13: ) The globally increasing incidence of diabetes mellitus and the accompanying metabolic syndrome has forced much attention on the early diagnosis and treatment thereof. Screening of patients at risk is recommended. The use of point-of-care testing (POCT) using glucose meters has been on the increase, especially in the primary health care setting. The use of POCT devices ensures a rapid turnaround and timely treatment of patients in the intensive care setting. The accuracy of POCT devices compared with laboratory glucose measurements is therefore an important factor to consider. The advantages of POCT, for example, low sample volume and decreased turnaround time, are negated if the results compare poorly From the Division of Chemical Pathology, National Health Laboratory Service, Tygerberg Hospital, Stellenbosch University, Cape Town, South Africa. Reprints: Megan Amelia Rensburg, MBChB, FC Path (SA), MMed (Chem Path), Division of Chemical Pathology, National Health Laboratory Service, Tygerberg Hospital, Stellenbosch University, PO Box 19113, Tygerberg, 7505 Cape Town, South Africa. rensburg@sun.ac.za. The authors declare no conflict of interest. Copyright 2014 by Lippincott Williams & Wilkins ISSN: X with laboratory-based measurements. The variability between the laboratory and glucose meter results is partly caused by userrelated issues, which can be addressed by training and appropriate quality control. Patient factors, such as hemodynamics and drug treatment, become important if glucose meters used are prone to interferences. Although monitoring of glucose is common among those with diabetes mellitus, it is not restricted to this population. Recent studies have suggested that tight glucose control decreases mortality in critically ill patients. Intensive care patients are on multiple medications and often have abnormal hematocrit and/or oxygenation. 1 These are factors known to affect the performance of glucose meters. Many studies have found that glucose meters demonstrate a positive bias at low hematocrit and a negative bias at high hematocrit. 2 In the South African setting, there is a high incidence of infectious diseases, especially human immunodeficiency virus with a prevalence of 17.9% (15 49 years), as reported in The increasing use of antiretroviral drugs with their adverse effects leads to a further increase in the metabolic disease burden in this patient population. Metabolic abnormalities, such as dyslipidemia and insulin resistance, are most commonly observed. 4 These are further increasing the burden of cardiovascular disease in the human immunodeficiency virus population. A new generation point-of-care glucose meter, the StatStrip glucose meter (Nova Biomedical, Waltham, Mass), has many unique features. It has a turnaround time of 6 seconds, only needs 1.2 μl of blood per measurement, and has the unique advantage of no hematocrit interference. StatStrip glucometer technology allows for simultaneous measurement of the hematocrit and the subsequent correction for abnormal measurements together with the glucose on the same strip. 5 Our aim was to assess the analytical performance of the StatStrip (Xpress and Connectivity) to 2 Accu-Chek Active meters (Roche Diagnostics, Mannheim, Germany), which are currently used in monitoring glucose in hospital and by patients in the public health sector in South Africa. Plasma glucose by the glucose oxidase method on the Siemens Advia 1800 (Siemens Diagnostics, Munich, Germany) was used as the reference method. Our second aim was to assess the glucose meters in a clinical setting. MATERIALS AND METHODS Setting Our laboratory is based in Tygerberg Academic Hospital (a 1310-bedded tertiary hospital) in Cape Town, South Africa, and serves approximately 3.6 million people in the Cape Metropole and surrounding rural areas. Instrumentation The reference assay used was the glucose oxidase method on the Siemens Advia 1800 (Siemens Diagnostics). Four glucose meters were used in this evaluation: 2 Accu-Chek Active meters Point of Care Volume 13, Number 4, December
2 Rensburg et al Point of Care Volume 13, Number 4, December 2014 TABLE 1. Correlation Data for Glucose Meters Versus Siemens Advia 1800 (n = 155)* Glucose Meter Slope Intercept, mmol/l R 2 Median Bias, mmol/l StatStrip Xpress StatStrip Connectivity Accu-Chek Accu-Chek *Data of only 1 lot number displayed as similar result obtained with other lot number strips. (Roche Diagnostics) that uses the glucose dehydrogenasepyrroloquinolinquinone electrochemical method and the StatStrip Xpress and Connectivity (Nova Biomedical) that use a modified glucose oxidase based amperometric technology with hematocrit correction. Two different strip lot numbers were analyzed on all 4 glucose meter instruments. Precision Studies Quality control material (3 levels with ranges ; ; and mmol/l) and spiked heparinized whole blood (3 levels with ranges ; ; and mmol/l) were used to assess the meters' precision. Laboratory-Based Method Correlation Donated patient/volunteer specimens (consented adults from the laboratory and medical outpatient department) heparinized venous whole blood were obtained and analyzed within 30 to 60 minutes of collection. A total of 155 blood samples were analyzed on the 4 glucose meters and then immediately centrifuged for measurement on the laboratory instrument Siemens Advia 1800 (Siemens Diagnostics). Twenty of these samples were spiked with various volumes of glucose concentrate to extend the glucose range. Clinical Method Correlation A group of 110 patients attending the diabetic outpatient clinic was recruited for this leg of the evaluation. Venous whole blood collected in a sodium fluoride tube was collected for analysis on the reference laboratory method (Siemens Advia 1800; glucose oxidase method) and a simultaneous finger-prick capillary blood sample was obtained and measured on the glucose meters (only the StatStrip Xpress and Connectivity meters; only 1 lot of strips was evaluated). FIGURE 1. Difference plots with ISO standard limits. A, StatStrip Xpress versus reference method (glucose oxidase). B, StatStrip Connectivity versus reference method (glucose oxidase). C, Accu-Chek Active 1 versus reference method (glucose oxidase). D, Accu-Chek Active 2 versus reference method (glucose oxidase) Lippincott Williams & Wilkins
3 Point of Care Volume 13, Number 4, December 2014 Performance of StatStrip Glucose Meter TABLE 2. Clinical Correlation Data for Glucose Meters Versus Siemens Advia 1800 (n = 110) Glucose Meter Slope Intercept, mmol/l R 2 Median Bias, mmol/l StatStrip Xpress StatStrip Connectivity Interference Testing and Hematocrit Study A single-donor volunteer (healthy, consented laboratory staff member) with normal hematocrit levels was selected for the evaluation of interfering substances and hematocrit effect. One hundred fifty milliliters of venous heparinized whole blood samples were collected from the single donor and allowed to sit at room temperature for 24 hours on a tube roller. Afterward, these samples were spiked with various concentrations of glucose and interfering substances. Interferences studied included maltose, xylose, ascorbic acid, and paracetamol (acetaminophen). The samples were spiked with various concentrations of glucose, and then, the interfering substances were added at various concentrations. The glucose was then determined using the glucose meters, followed by immediate centrifugation and measurement of plasma glucose on the laboratory instrument. Various hematocrit levels were prepared from the single-donor sample using fresh heparinized whole blood, which was also allowed to sit at room temperature for approximately 24 hours. This sample was divided into 3 aliquots and spiked with concentrated glucose to achieve 3 different glucose levels. These were then further divided into 5 aliquots of 1 ml, which were centrifuged (Corning LMS Mini Microcentrifuge, Tewksbury, Mass) and plasma adjusted (taking plasma from 1 tube and adding to another), to obtain 5 samples each with a different hematocrit (percent) level for each of the 3 glucose levels. The samples were rocked for 10 minutes, analyzed on the glucose meters, and afterward, centrifuged for plasma glucose determination on the Siemens Advia 1800 (Siemens Diagnostics). Hematocrit values were measured on these samples using the Mini- Hematocrit centrifuge (Hawksley, England). Ethical Consideration Ethical approval was obtained from the ethics and research committee of the Stellenbosch University, and all patients and volunteer donors were consented before blood collection. Statistical Analysis Interference and Hematocrit Experiment The results were expressed as mean change from the baseline glucose (meter glucose with interfering substance meter glucose at baseline) expressed as a percentage change. Method Correlation Correlation statistics including regression analysis and Bland- Altman statistics were analyzed using the Analyse-it software version 2.30 and Microsoft Excel The ISO standard was used to confirm accuracy. 6 The standard states that glucose values should fall within 0.8 mmol/l of the clinical laboratory reference method for 95% of values below 4.2 mmol/l or within 20% of the clinical laboratory reference method for values above 4.2 mmol/l. (Since this study, the standard has been revised to ISO 15197:2013.) RESULTS Precision Within-run and between-run precisions were assessed using 3 levels of quality control and 3 levels of spiked whole blood samples. All of the glucose meters achieved precision of less than 5% at all levels. Laboratory Correlation Experiment Correlation between the glucose meter results and plasma glucose oxidase reference method was performed by analyzing 155 fresh lithium heparin venous blood specimens. Linear regression equations and R 2 statistics are displayed in Table 1. The Xpress meter showed an R 2 of and and the Connectivity meter showed an R 2 of and for both strip lots. The excellent correlations were achieved using both normal FIGURE 2. Difference plots with ISO standard limits (clinical correlation). A, StatStrip Xpress versus reference method (glucose oxidase). B, StatStrip Connectivity versus reference method (glucose oxidase) Lippincott Williams & Wilkins 139
4 Rensburg et al Point of Care Volume 13, Number 4, December 2014 FIGURE 3. Ascorbic acid interference plot. and abnormal samples and using samples that had potential glucose-interfering substances. Overall, the Nova meters averaged less than 2% accuracy error and had slopes averaging approximately 0.960, with Y intercepts of close to 0 across both strip lots tested. These data confirm that the Nova meters had almost perfect correlation and agreement to the laboratory reference method with no interference effects. The Roche Active meters used in the testing showed R 2 values of and for the first meter and and for the second meter over both strip lots. These correlation coefficients were much lower than those for the Nova StatStrip, and in addition, they averaged approximately 15% accuracy error across both strip lots tested. The Roche meters seem to have an overall positive results bias versus the reference method. The StatStrip meters met the recommended ISO clinical accuracy standard on 100 % of all specimens with no bias data trend observed. The Roche Active meters used in the study were only able to meet the ISO standard for 80% of the samples tested for results up to 4.2 mmol/l and only for 91% of the samples tested for samples more than 4.2 mmol/l. In addition, the Roche devices showed a positive result bias overall for low through high samples comparing with the laboratory reference system (Figs. 1A D). Clinical Correlation Study The Xpress meter showed an R 2 of 0.97 and the Connectivity meter showed an R 2 of Linear regression equation and R 2 statistics are displayed in Table 2. The StatStrip meters met the recommended ISO clinical accuracy standard on more than 95% of the specimens (Figs. 2A, B). Interfering Substances The Roche Active meters were slightly affected by paracetamol (acetaminophen) present in normal level glucose whole blood samples. Accuracy errors for the reference range glucose samples ranged from 8% to 19% across both strip lots tested. Unlike the Roche meters, the StatStrip meters were not affected at any levels by the presence of acetaminophen in the blood samples. Nova accuracy errors averaged less than 5% versus the reference method across both strips lots tested and all glucose levels. The Roche data however indicated falsely elevated glucose results on normal level glucose samples because of high-level interference from ascorbic acid (Fig. 3). Acetaminophen interference at different concentration levels (0.29 and 0.59 mmol/l) was tested at 5 different glucose levels (range, mmol/l). The Roche Active meters were affected by the presence of ascorbic acid in the low and normal whole blood samples. Accuracy errors for the low and reference range glucose samples ranged from as little as 10% up to 81% across both strip lots tested. Unlike the Roche meters, the StatStrip meters were not affected by the presence of ascorbic acid in the blood samples. StatStrip accuracy errors averaged approximately 5% to 8% versus the reference method across both strips lots tested and all glucose levels. Maltose with final concentrations of 2.8 and 5.6 mmol/l and xylose (final concentrations, 5.6 and 11.1 mmol/l) were added to donor blood samples with concentrations of 1.9, 6.6, and 23.5 mmol/l. The Roche Active meters were severely affected bythepresenceofbothmaltoseandxyloseinthewholeblood samples. The accuracy errors varied, depending on glucose level. The Roche meters showed accuracy errors of between 12% and 42% across midrange- and high-glucose samples and showed errors of 77% to 652% across reference- and low-range glucose samples. Unlike the Roche meters, the StatStrip meters were not affected by nonglucose sugars in the blood samples. The Nova accuracy errors averaged approximately 2% versus the reference method across both maltose and xylose levels at all glucose levels (Figs. 4A, B). Hematocrit Effect Results from this study showed that the Nova StatStrip had average accuracy errors compared with the reference method of less than 5%, whereas the Roche Active had accuracy errors of up to 17% versus the reference method at low-hematocrit levels and up to 21% accuracy errors at high-hematocrit levels across low- through high-glucose levels. In addition, the Roche meters results at low- and high-hematocrit levels differed from itself at normal hematocrit level by up 22% on the same glucose samples. FIGURE 4. A and B, Maltose and xylose interference plots Lippincott Williams & Wilkins
5 Point of Care Volume 13, Number 4, December 2014 Performance of StatStrip Glucose Meter FIGURE 5. Influence of hematocrit (percent) on glucose measurement. A, Glucose is equal to 21 mmol/l. B, Glucose is equal to 13.2 mmol/l. The results were confirmed by testing on 2 different strip lots of Nova and Roche strips (Fig. 5). DISCUSSION Glucose meters are commonly used in an array of different clinical setting and patients. The accuracy and precision of these and most other POCT instruments are an often-neglected area. Our findings have highlighted the importance of having knowledge on the instrument's performance and possible interferences. These glucose meters are used in settings where clinicians and patients will use results to guide therapy. It is therefore imperative that the glucose meter produces a result that is comparative with central laboratory test results. In our evaluation, all the meters displayed an acceptable imprecision. The meters however differed in performance when compared with the reference laboratory method (glucose oxidase). This difference has been observed in previous studies. 5,7,8 The StatStrip meters demonstrated the closest correlation with the laboratory method. It met the ISO criteria because 100% of all data points were within the limits of this standard. The Accu-Chek meters did not meet the ISO criteria and overall showed a positive bias. This positive bias can become problematic in both low- and high-glucose ranges, leading to undertreatment and possibly missed hypoglycemia in the low-glucose range. Overtreatment in the higher glucose range poses the danger of inducing hypoglycemia, when treatment (eg, insulin) is adjusted in response to high-glucose levels. Boyd and Bruns 8 have demonstrated that, at a 10% total error, 16% to 45% of sliding-scale insulin doses would be in error, although small, but larger dosing errors were common when the total error was between 10% and 15%. 9 The effects of various commonly used medications have been observed. Paracetamol showed minimal interference on the Accu- Chek meters, whereas no interference was observed on the StatStrip instruments. Similarly, the StatStrip meters displayed no influence on high ascorbic acid concentrations but displayed significant interference with the Accu-Chek meters. Maltose interference is known to meters using the glucose dehydrogenase pyrroloquinolinquinone methodology and was found significant for the Accu-Chek meters. 10 The effect of hematocrit on the glucose meters was demonstrated by preparing samples with varying hematocrit values (22% 67%) and 3 different glucose concentrations. This exercise demonstrated clearly that the StatStrip meters were unaffected by hematocrit, whereas the Accu-Check meters both showed significant influence (inverse association). Hematocrit values can vary widely in the critically ill patients and are known to be high in the neonatal population. Multiple studies have before demonstrated the effect of hematocrit on POCT glucose instruments Awareness of the hematocrit interference is thus crucial when a glucose meter with known interference is being used in these patient groups. In conclusion, the StatStrip glucose meter outperformed the Accu-Check meters and was unaffected or minimally impacted by variables such as hematocrit and interfering substances, such as maltose and xylose. The StatStrip technology may improve the practice of glucose monitoring, especially in the critically ill and neonatal population. ACKNOWLEDGMENT The authors thank Scientific Group (Pty) Ltd. South Africa for supplying the reagents and equipment for the evaluation. REFERENCES 1. Bhansali D, Harjindar S, Rogers Peretti A, et al. Comparative testing for better glycemic control. LabMedicine. 2009;40(8): Holtzinger C, Szelag E, DuBois JA, et al. Evaluation of a new POCT bedside glucose meter and strip with hematocrit and interference corrections. Point of Care.2008;7(1): HIV and AIDS estimates. Available at: regionscountries/countries/southafrica/. Accessed January 20, Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med. 2005;352: Karon B, Griesmann L, Scott R, et al. Evaluation of the impact of hematocrit and other interference on the accuracy of hospital-based glucose meters. Diabetes Technol Ther. 2008;10(2): ISO 15197:2003. In vitro diagnostic test systems Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. Geneva, Switzerland: WHO; Essack Y, Hoffman M, Rensburg MA, et al. A comparison of five glucometers in South Africa. JEMDSA. 2009;14(2): Chen E, Nichols J, Duh S, et al. Performance evaluation of blood glucose monitoring devices. Diabetes Technol Ther. 2003;5: Boyd JC, Bruns DE. Quality specifications for glucose meters: assessment by simulation modeling of errors in insulin dose. Clin Chem. 2001;47: FDA Alert: FDA reminds healthcare professionals about falsely elevated glucose levels. Available at: Safety/AlertsandNotices/PublicHealthNotifications/ucm htm. Accessed January 20, Tang Z, Du X, Louie R, et al. Effects of drugs on glucose measurements with handheld glucose meters and a portable glucose analyzer. Am J Clin Pathol. 2000;113: Tang Z, Du X, Louie R, et al. Effects of different hematocrit levels on glucose measurements with handheld meters for point-of-care testing. Am J Clin Pathol. 2000;124: Louie R, Tang Z, Sutton D, et al. Point-of-care testing: effects of critical care variables, influence of reference instruments, and a modular glucose meter design. Arch Pathol Lab Med. 2000;124: Lippincott Williams & Wilkins 141
A comparison of blood glucose meters in Australia
Diabetes Research and Clinical Practice 71 (2006) 113 118 www.elsevier.com/locate/diabres A comparison of blood glucose meters in Australia Matthew Cohen *, Erin Boyle, Carol Delaney, Jonathan Shaw International
More informationEvaluation of Accuracy and User Performance of the TRUE METRIX Self-Monitoring Blood Glucose System *
Evaluation of Accuracy and User Performance of the TRUE METRIX Self-Monitoring Blood Glucose System * Summary Objectives: To demonstrate that the TRUE METRIX Self-Monitoring Blood Glucose System*, from
More informationAn important first step in identifying those at risk for Cardiovascular disease The Accutrend Plus system: from the makers of the ACCU-CHEK and
An important first step in identifying those at risk for Cardiovascular disease The Accutrend Plus system: from the makers of the ACCU-CHEK and CoaguChek systems Cardiovascular disease: the #1 killer in
More informationPractice Advisory Blood Glucose Meter Accuracy Issued September 16, 2013
Practice Advisory Blood Glucose Meter Accuracy Issued September 16, 2013 For the person with diabetes, blood glucose monitoring provides immediate feedback on the effects of daily activities such as taking
More informationUSING CLSI GUIDELINES TO PERFORM METHOD EVALUATION STUDIES IN YOUR LABORATORY
USING CLSI GUIDELINES TO PERFORM METHOD EVALUATION STUDIES IN YOUR LABORATORY Breakout Session 3B Tuesday, May 1 8:30 10 am James Blackwood, MS, CLSI David D. Koch, PhD, FACB, DABCC, Pathology & Laboratory
More informationSMF Awareness Seminar 2014
SMF Awareness Seminar 2014 Clinical Evaluation for In Vitro Diagnostic Medical Devices Dr Jiang Naxin Health Sciences Authority Medical Device Branch 1 In vitro diagnostic product means Definition of IVD
More informationTitle: Glucose Testing: StatStrip Glucose Meter Page 1 of 6
Title: Glucose Testing: StatStrip Glucose Meter Page 1 of 6 CentraCare Health (CCH) adopts the following policy/procedure for: St. Cloud Hospital Original: 5/02 Minor Revision: Full Review: 1/15 Replaces:
More informationFDA Public Hearing on Clinical Accuracy Requirements for Point of Care Blood Glucose Meters (BGMs)
FDA Public Hearing on Clinical Accuracy Requirements for Point of Care Blood Glucose Meters (BGMs) Barriers to Overcoming Interferences and Limitations Alan T. Cariski, MD, JD, and Mike Flis, AdvaMed BGM
More informationBlood Glucose Monitoring: The Facts about Accuracy
Blood Glucose Monitoring: The Facts about Accuracy Summary The purpose of this document is to provide the facts about the accuracy of self-monitoring of blood glucose (SMBG) systems. Accuracy can be defined
More informationSamsung POINT OF CARE Systems - Cardiac/Acute Care Biomarkers LABGEO IB Clinical Chemistry Analytes LABGEO PT
Samsung POINT OF CARE Systems - Cardiac/Acute Care Biomarkers LABGEO IB Clinical Chemistry Analytes LABGEO PT Alexander Belenky, PhD Director -Product Development Samsung - Nexus-Dx Edward Brennan, PhD
More informationSAMPLE. Effects of Different Sample Types on Glucose Measurements
1st Edition POCT06 Effects of Different Sample Types on Glucose Measurements This report provides information to assist the clinical and point-ofcare staff in result and measurement procedure comparisons
More informationBiochemistry Validation Form
Biochemistry Validation Form Method: Piccolo Xpress Chemistry 13 panel Manufacturer: Abaxis Cat no: 400-0029 CE marked: Yes: x No: Location of bench book: X:\Bio\Patricia\Piccollo Xpress evaluation (August
More informationA Self-Study Packet for The Johns Hopkins Hospital Point-of-Care Testing Program copyright 2011 Johns Hopkins Hospital All rights reserved
A Self-Study Packet for The Johns Hopkins Hospital Point-of-Care Testing Program copyright 2011 Johns Hopkins Hospital All rights reserved Overview and Objectives This module provides an introduction to
More informationPROCEDURE NO. POC.514.01 LBH. Printed copies are for reference only. Please refer to the electronic copy for the latest version.
Department Of Pathology POC.514.01- Blood Glucose Monitoring Accu-Chek Inform II Procedure-LBH Version# 1 Department PROCEDURE NO. PAGE NO. Point-of-Care Testing POC.514.01 LBH 1 OF 7 Printed copies are
More informationValidation of measurement procedures
Validation of measurement procedures R. Haeckel and I.Püntmann Zentralkrankenhaus Bremen The new ISO standard 15189 which has already been accepted by most nations will soon become the basis for accreditation
More informationAccuracy Test Omnitest 3 Blood Glucose Monitoring System. B. Braun Diabetes Care
Accuracy Test Omnitest Blood Glucose Monitoring System B. Braun Diabetes Care Accuracy Test Omnitest blood glucose monitoring system according to ISO 97 The accuracy study of Omnitest blood glucose monitoring
More informationPerformance Variability of Seven Commonly Used Self-Monitoring of Blood Glucose Systems: Clinical Considerations for Patients and Providers
Journal of Diabetes Science and Technology Volume 7, Issue 1, January 2013 Diabetes Technology Society ORIGINAL ARTICLE Performance Variability of Seven Commonly Used Self-Monitoring of Blood Glucose Systems:
More informationHow To Test For Creatinine
Creatinine is measured amperometrically. Creatinine is hydrolyzed to creatine in a reaction catalyzed by the enzyme creatinine amidohydrolase. Creatine is then hydrolyzed to sarcosine in a reaction catalyzed
More informationBlood Glucose Monitoring Test Systems for Prescription Point-of- Care Use Draft Guidance for Industry and Food and Drug Administration Staff
Blood Glucose Monitoring Test Systems for Prescription Point-of- Care Use Draft Guidance for Industry and Food and Drug Administration Staff GUIDANCE guidance. Submit written comments to the Division of
More informationTextbook: Chapter 12 pages 351-353, Chapter 13 pages 385-388
EXERCISE 11: BEDSIDE GLUCOSE TESTING Textbook: Chapter 12 pages 351-353, Chapter 13 pages 385-388 Skills: Objectives: 15 points 1. List the limitations of the bedside glucose test procedure. 2. State the
More informationI know my value. CoaguChek XS Plus system Smart INR monitoring at your practice. 1 of 6
I know my value CoaguChek XS Plus system Smart INR monitoring at your practice 1 of 6 CoaguChek XS Plus system A better choice for your patients and your practice There has been an extraordinary increase
More information510(K) SUMMARY FEB - 12008. Submitter: Name of the device: * Common Name: Clinical Chemistry Analyzer (with optional ISE Module) Attachment #2
Attachment #2 510 (k) Summary 510(K) SUMMARY FEB - 12008 This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.
More informationPoint-of-care (POC) versus central laboratory instrumentation for monitoring oral anticoagulation
Point-of-care (POC) versus central laboratory instrumentation for monitoring oral anticoagulation David M Dorfman a, Ellen M Goonan a, M Kay Boutilier a, Petr Jarolim a, Milenko Tanasijevic a and Samuel
More informationD-Facts. Vitamin D Competitive Evaluation
D-Facts Vitamin D Competitive Evaluation Abstract 101 patient samples collected across sites in Germany were used to compare the performance of the Siemens ADVIA Centaur Vitamin D Total (VitD), Abbott
More informationHEMATOCRIT/HCT AND CALCULATED HEMOGLOBIN/HB
HEMATOCRIT/HCT AND CALCULATED HEMOGLOBIN/HB Hematocrit is determined conductometrically. The measured conductivity, after correction for electrolyte concentration, is inversely related to the hematocrit.
More informationQuality Requirements of a Point of Care Testing Service
Quality Requirements of a Point of Care Testing Service Adil I. Khan MSc, PhD Assistant Professor of Pathology Director of Point of Care Testing & Clinical Chemistry Laboratory, Temple University Episcopal
More information4/24/2015. Urgent, STAT, Super STAT, ASAP! Achieving timely lab testing for the Emergency Department. Learning Objectives.
Urgent, STAT, Super STAT, ASAP! Achieving timely lab testing for the Emergency Department Nichole Korpi-Steiner, PhD, DABCC, FACB University of North Carolina Chapel Hill, NC Learning Objectives Describe
More informationInform II. Quick Reference Guide. for Healthcare Professionals BLOOD GLUCOSE MONITORING SYSTEM
Inform II BLOOD GLUCOSE MONITORING SYSTEM Quick Reference Guide for Healthcare Professionals 2 Table of Contents Important... 4 General Information... 6 ACCU-CHEK Inform II Meter...10 How to Perform Patient
More information25-hydroxyvitamin D: from bone and mineral to general health marker
DIABETES 25 OH Vitamin D TOTAL Assay 25-hydroxyvitamin D: from bone and mineral to general health marker FOR OUTSIDE THE US AND CANADA ONLY Vitamin D Receptors Brain Heart Breast Colon Pancreas Prostate
More informationPOCT in diagnosing and monitoring of Diabetes Mellitus. 13th EFLM Continuous Postgraduate Course, Sverre Sandberg, Noklus / EFLM
POCT in diagnosing and monitoring of Diabetes Mellitus - 13th EFLM Continuous Postgraduate Course, Sverre Sandberg, Noklus / EFLM The most important constituents - Glucose monitoring and diagnosing - U-albumin
More informationComparison of Glucose Determinations on Blood Samples Collected in Three Types of Tubes
278 Available online at www.annclinlabsci.org Comparison of Glucose Determinations on Blood Samples Collected in Three Types of Tubes Geling Li 1,2, Michael Cabanero 1,2, Zhenglong Wang 1,2, Huiying Wang
More informationFact Sheet for Health Care Providers: Interpreting Results from the Aptima Zika Virus Assay. June 17, 2016
Dear Health Care Provider: Fact Sheet for Health Care Providers: Interpreting Results from the Aptima Zika Virus Assay June 17, 2016 The U.S. Food and Drug Administration (FDA) has issued an Emergency
More informationTitle: Fingerstick Glucose by Accu-Chek Inform
Title: Fingerstick Glucose by Accu-Chek Inform Target Audience: This module is available to aid in assessing competency for all clinical staff who perform fingerstick glucose testing. Contents Instructions...
More informationValidation and Calibration. Definitions and Terminology
Validation and Calibration Definitions and Terminology ACCEPTANCE CRITERIA: The specifications and acceptance/rejection criteria, such as acceptable quality level and unacceptable quality level, with an
More informationA guidebook for people with diabetes
A guidebook for people with diabetes This booklet is designed to supplement, not replace, your doctor s advice. Please consult your doctor if you have any questions about what you read. You ll learn how
More informationThe sensitive marker for glomerular filtration rate (GFR) Estimation of GFR from Serum Cystatin C:
The sensitive marker for glomerular filtration rate (GFR) Estimation of GFR from Serum Cystatin C: The good correlation allows close estimation of GFR Cystatin C GFR GFR in serum estimated* measured* n
More informationLab 2. Spectrophotometric Measurement of Glucose
Lab 2 Spectrophotometric Measurement of Glucose Objectives 1. Learn how to use a spectrophotometer. 2. Produce a glucose standard curve. 3. Perform a glucose assay. Safety Precautions Glucose Color Reagent
More informationQuality Control of the Future: Risk Management and Individual Quality Control Plans (IQCPs)
Quality Control of the Future: Risk Management and Individual Quality Control Plans (IQCPs) James H. Nichols, PhD, DABCC, FACB Professor of Pathology, Microbiology, and Immunology Medical Director, Clinical
More informationWorldwide Markets and Emerging Technologies for Point-of-Care Testing, 2013-2019. February 2015
Worldwide Markets and Emerging Technologies for Point-of-Care Testing, 2013-2019 February 2015 INTELAB CORPORATION MARKET AND TECHNOLOGY REPORTS Report 530 Copyright 2015 Worldwide Markets and Emerging
More informationPoint of Care HIV Viral Load Testing:
Point of Care HIV Viral Load Testing: Lesley Scott, Natasha Gous, Shuqi Chen *, Wendy Stevens Department of Molecular Medicine and Haematology University of the Witwatersrand, National Health Laboratory
More informationCenter for Clinical Standards and Quality/Survey & Certification Group
DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services 7500 Security Boulevard, Mail Stop C2-21-16 Baltimore, Maryland 21244-1850 Center for Clinical Standards and Quality/Survey
More informationGlobal Clinical Laboratory Testing Market Report: 2012 Edition
Brochure More information from http://www.researchandmarkets.com/reports/2165640/ Global Clinical Laboratory Testing Market Report: 2012 Edition Description: Clinical laboratory testing market is one of
More informationPRINCIPLE. REF 442635 (200 tests/cartridge) REF 476836 (400 tests/cartridge) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE
SYNCHRON System(s) Chemistry Information Sheet Copyright 2010 Beckman Coulter, Inc. Creatine Kinase REF 442635 (200 tests/cartridge) REF 476836 (400 tests/cartridge) For In Vitro Diagnostic Use ANNUAL
More informationCaution! Please read complete Owner s Booklet and all product Instructions for Use.
INTRODUCTION: Liberty Blood Glucose Monitoring System The Liberty System is a simple, accurate way to test whole blood glucose (sugar) level, anytime, anywhere. Our goal is to provide quality healthcare
More informationtips Insulin Pump Users 1 Early detection of insulin deprivation in continuous subcutaneous 2 Population Study of Pediatric Ketoacidosis in Sweden:
tips Top International Publications Selection Insulin Pump Users Early detection of insulin deprivation in continuous subcutaneous insulin infusion-treated Patients with TD Population Study of Pediatric
More informationPrognostic impact of uric acid in patients with stable coronary artery disease
Prognostic impact of uric acid in patients with stable coronary artery disease Gjin Ndrepepa, Siegmund Braun, Martin Hadamitzky, Massimiliano Fusaro, Hans-Ullrich Haase, Kathrin A. Birkmeier, Albert Schomig,
More informationDevelopment and Validation of In Vitro Diagnostic Tests. YC Lee, Ph.D. CEO
Development and Validation of In Vitro Diagnostic Tests YC Lee, Ph.D. CEO 1 Validation of In Vitro Diagnostic Tests Validated d Diagnostic Test should: Provides test results that identify if positive i
More informationSKUP Scandinavian evaluation of laboratory equipment for primary health care
SKUP Scandinavian evaluation of laboratory equipment for primary health care ACCU-CHEK Aviva Meter and test strips designed for glucose self-measurement Manufactured by Roche Diagnostics GmbH Report from
More information510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY DEVICE AND INSTRUMENT TEMPLATE
510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY DEVICE AND INSTRUMENT TEMPLATE A. 510(k) Number: K041502 B. Purpose for Submission: To change the name of a previously cleared analyzer, and
More informationMethod Validation/Verification. CAP/CLIA regulated methods at Texas Department of State Health Services Laboratory
Method Validation/Verification CAP/CLIA regulated methods at Texas Department of State Health Services Laboratory References Westgard J. O.: Basic Method Validation, Westgard Quality Corporation Sarewitz
More informationBlood Sugar Monitoring
Sugar Monitoring Know Your Sugar Numbers Taking control of your diabetes and blood glucose (blood sugar) can make you feel better and stay healthy. Research shows that maintaining your blood glucose level
More informationUnaccredited Point-of-Care Laboratory Testing Guideline for Physicians
Unaccredited Point-of-Care Laboratory Testing Guideline for Physicians Prepared by the Advisory Committee on Laboratory Medicine College of Physicians & Surgeons of Alberta Serving the Public by guiding
More informationUnderstanding Analytical Chemistry (Weighing, Mixing, Measuring and Evaluating)
Name: Date: Understanding Analytical Chemistry (Weighing, Mixing, Measuring and Evaluating) High School Environmental Science AP Module 1 Environmental Lab NGSSS Big Ideas: This module is a laboratory-based
More informationInc. Wuhan. Quantity Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4 Standard (liquid) 2
Uscn Life Science Inc. Wuhan Website: www.uscnk.com Phone: +86 27 84259552 Fax: +86 27 84259551 E-mail: uscnk@uscnk.com ELISA Kit for Human Prostaglandin E1(PG-E1) Instruction manual Cat. No.: E0904Hu
More informationSTANDARD OPERATING PROCEDURE FOR NOVA STAT STRIP CONNECTIVITY BLOOD GLUCOSE METERS FOR USE IN LEEDS NHS TRUST
STANDARD OPERATING PROCEDURE FOR NOVA STAT STRIP CONNECTIVITY BLOOD GLUCOSE METERS FOR USE IN LEEDS NHS TRUST This Standard Operating Procedure explains the protocol for measuring blood glucose concentration
More informationFor In Vitro Diagnostic Use
SYNCHRON System(s) Chemistry Information Sheet Creatine Kinase REF (200 tests/cartridge) 442635 REF (400 tests/cartridge) 476836 For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed by: Reviewed by: Date
More informationCode of practice for clinical biochemists/chemical pathologists. and clinical biochemistry services. March 2011
Code of practice for clinical biochemists/chemical pathologists and clinical biochemistry services March 2011 Unique document number Document name Version number 2 Produced by G027 Date active March 2011
More informationTOTAL PROCESS MANAGEMENT FOR YOUR NEWBORN SCREENING LABORATORY. Specimen Gate software
TOTAL PROCESS MANAGEMENT FOR YOUR NEWBORN SCREENING LABORATORY Specimen Gate software MANAGE YOUR ENTIRE SCREENING PROCESS Newborn screening generates vast amounts of data that require continuous tracking.
More informationHomeostatic Model Assessment (HOMA)
Homeostatic Model Assessment (HOMA) Historically, insulin resistance (IR) was measured with an invasive test called a euglycemic clamp test. Basically it s a test to measure how much insulin a person needs
More informationAccu-Chek Inform II system. Professional glucose testing for the wireless age
Accu-Chek Inform II system Professional glucose testing for the wireless age The Accu-Chek Inform II system Real time control The Accu-Chek Inform II System overview Quality Advanced chemistry with multiple
More informationBACKGROUND. ADA and the European Association recently issued a consensus algorithm for management of type 2 diabetes
BACKGROUND More than 25% of people with diabetes take insulin ADA and the European Association recently issued a consensus algorithm for management of type 2 diabetes Insulin identified as the most effective
More informationAbstract... i. Committee Membership... iii. Foreword... vii. 1 Scope... 1. 2 Introduction... 1. 3 Standard Precautions... 1. 4 Definitions...
Vol. 27 No. 26 Replaces H3-A5 Vol. 23 No. 32 Procedures for the Collection of Diagnostic Blood Specimens by Venipuncture; Approved Standard Sixth Edition This document provides procedures for the collection
More informationEfficacy and Safety of Insulin Aspart in Patients with Type 1 Diabetes Mellitus
Clin Pediatr Endocrinol 2002; 11(2), 87-92 Copyright 2002 by The Japanese Society for Pediatric Endocrinology Original Efficacy and Safety of Insulin Aspart in Patients with Type 1 Diabetes Mellitus Toshikazu
More informationAnalytical Methods: A Statistical Perspective on the ICH Q2A and Q2B Guidelines for Validation of Analytical Methods
Page 1 of 6 Analytical Methods: A Statistical Perspective on the ICH Q2A and Q2B Guidelines for Validation of Analytical Methods Dec 1, 2006 By: Steven Walfish BioPharm International ABSTRACT Vagueness
More informationPreface. Preface. A Healthcare professional should be contacted when Customer Service is not available.
Preface Preface Thank you for selecting the GE100 Monitoring System. This manual provides all the information you need to operate this product for accurate test results. Please read the entire manual before
More informationA Fuzzy Controller for Blood Glucose-Insulin System
Journal of Signal and Information Processing, 213, 4, 111-117 http://dx.doi.org/1.4236/jsip.213.4215 Published Online May 213 (http://www.scirp.org/journal/jsip) 111 Ahmed Y. Ben Sasi 1, Mahmud A. Elmalki
More informationAarhus University Hospital Validation Tempus600 Transport system for blood tube samples. Pediatric blood samples
Aarhus University Hospital Validation Tempus6 Transport system for blood tube samples Pediatric blood samples Department of Clinical Biochemistry, SKS January 213 Aarhus Universitetshospital Inflammationscenteret
More informationAusBiotech submission regarding proposed performance requirements and risk mitigation strategies for HIV tests
AusBiotech submission regarding proposed performance requirements and risk mitigation strategies for HIV tests To: Medical Device Reforms Office of Devices Authorisation Therapeutic Goods Administration
More informationKetones & diabetes; Reduce your risk!
Ketones & diabetes; Reduce your risk! Booklet includes Sick Day Wallet Card Ketones 101 Do I really need to know this? by Helen Jones RN, MSN, CSE YES! The word Ketone is important for you to know if you
More informationChapter 14 Urinalysis, Body Fluids and Other Specimens. Objectives:
EXERCISE 15: CHEMICAL EXAMINATION OF URINE Textbook: Skill: Chapter 14 Urinalysis, Body Fluids and Other Specimens 15 points Objectives: 1. Name 10 routine chemical tests performed on urine and list a
More informationSample Analysis Design Step 2 Calibration/Standard Preparation Choice of calibration method dependent upon several factors:
Step 2 Calibration/Standard Preparation Choice of calibration method dependent upon several factors: 1. potential matrix effects 2. number of samples 3. consistency of matrix across samples Step 2 Calibration/Standard
More informationApplication Sheet for Rivaroxaban (Xarelto ) Standard Range with. BIOPHEN Heparin LRT (#221011/221013) RUO
Instrument Adaptation The attached instrument adaptation has been prepared and validated by the reagent manufacturer, Hyphen-Biomed. Instrument Siemens BCS-XP Product BIOPHEN Heparin LRT Analyte Rivaroxaban
More informationFeeling sick? What to do. Information for people with Type 1 Diabetes
Feeling sick? What to do Information for people with Type 1 Diabetes Diabetes and sick days A minor illness can result in a major rise in blood glucose levels Common illnesses such as tonsillitis, ear,
More informationCHAPTER THREE COMMON DESCRIPTIVE STATISTICS COMMON DESCRIPTIVE STATISTICS / 13
COMMON DESCRIPTIVE STATISTICS / 13 CHAPTER THREE COMMON DESCRIPTIVE STATISTICS The analysis of data begins with descriptive statistics such as the mean, median, mode, range, standard deviation, variance,
More informationPreparation "Clinical Laboratory Technologist and Technician Overview"
Clinical Laboratory Technologist and Technician Overview The Field - Preparation - Day in the Life - Earnings - Employment - Career Path Forecast - Professional Organizations The Field Clinical laboratory
More informationURINE DIPSTICK Multistix 10SG
The Johns Hopkins Hospital Point-of-Care Testing Program URINE DIPSTICK Multistix 10SG Operator Competency Only operators who have completed a defined training program and can demonstrate competence will
More informationObesity in the United States Workforce. Findings from the National Health and Nutrition Examination Surveys (NHANES) III and 1999-2000
P F I Z E R F A C T S Obesity in the United States Workforce Findings from the National Health and Nutrition Examination Surveys (NHANES) III and 1999-2000 p p Obesity in The United States Workforce One
More informationContent Sheet 7-1: Overview of Quality Control for Quantitative Tests
Content Sheet 7-1: Overview of Quality Control for Quantitative Tests Role in quality management system Quality Control (QC) is a component of process control, and is a major element of the quality management
More informationFETAL SCALP LACTATE RESEARCH STUDY COMPARISON OF TWO POINT OF CARE METERS
FETAL SCALP LACTATE RESEARCH STUDY COMPARISON OF TWO POINT OF CARE METERS Presentation to Healthy Mothers, Healthy Babies Conference Perinatal Services BC February 22 nd, 2014 Ivy Fernando, RN BSN, PNC(C)
More informationGLUCOSE TOLERANCE (FOR DIABETESMELLITUS)- NON-PREGNANT ADULT/CHILDREN (Under 18 years old) (OGTT)
GLUCOSE TOLERANCE TESTING GESTATIONAL DIABETIC SCREEN (GDS2) GLUCOSE TOLERANCE (FOR DIABETESMELLITUS)- NON-PREGNANT ADULT/CHILDREN (Under 18 years old) (OGTT) GLUCOSE 2-HR POST-GLUCOSE LOAD (2HGPL)-SCREEN
More informationUrinalysis Compliance Tools. POCC Webinar January 19, 2011 Dr. Susan Selgren
Urinalysis Compliance Tools POCC Webinar January 19, 2011 Dr. Susan Selgren Learning Objectives Be able to review and improve upon a laboratory plan for compliance including: Competency Documentation Proficiency
More informationCK-MB TEST CARD 004A302
A rapid test for the qualitative detection of CK-MB in whole blood, serum or plasma. For professional in vitro diagnostic use only. INTENDED USE The CK-MB test card is a rapid chromatographic immunoassay
More informationOneStep Fecal Occult Blood RapiDip InstaTest. Cat # 13020-1
CORTEZ DIAGNOSTICS, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 USA Tel: (818) 591-3030 Fax: (818) 591-8383 E-mail: onestep@rapidtest.com Web site: www.rapidtest.com See external label
More informationLABORATORY PROCEDURE MANUAL
Exercise 2 Donor Physical Exam Textbook: Skills: 20 points Objectives 1. For each of the following state the acceptable values for blood donation using appropriate units: a. Pulse b. Temperature (Celsius
More informationMeasures of diagnostic accuracy: basic definitions
Measures of diagnostic accuracy: basic definitions Ana-Maria Šimundić Department of Molecular Diagnostics University Department of Chemistry, Sestre milosrdnice University Hospital, Zagreb, Croatia E-mail
More informationADMINISTRATIVE MANUAL Policy and Procedure
ADMINISTRATIVE MANUAL Policy and Procedure TITLE: Point of Care Testing NUMBER: CH 30-111 (Laboratory Diagnostic Bedside Testing) Effective Date: January 2014 Page 1 of 6 Applies To: Holders of Administrative
More informationGuidance for Industry
Guidance for Industry Q2B Validation of Analytical Procedures: Methodology November 1996 ICH Guidance for Industry Q2B Validation of Analytical Procedures: Methodology Additional copies are available from:
More informationSelf-Monitoring of Blood Glucose
My Doctor Says I Should Monitor My Blood Glucose... What Does This Mean? BD Getting Started Self-Monitoring of Blood Glucose Daily Blood Sugar Monitoring When you have diabetes, managing your blood glucose
More informationBLOOD GLUCOSE METER. Getting Started Guide for Single Patient Use Only
BLOOD GLUCOSE METER Getting Started Guide for Single Patient Use Only Before You Start Testing About the meter and test strips Carefully read and follow the instructions in the Getting Started Guide,
More informationInsulin-Treated Diabetes. Guidelines for assessment of fitness to work as Cabin Crew
Insulin-Treated Diabetes Guidelines for assessment of fitness to work as Cabin Crew General Considerations As with all medical guidelines it is important that each individual case is assessed on its own
More informationA prospective study on drug utilization pattern of anti-diabetic drugs in rural areas of Islampur, India
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2015, 7 (5):33-37 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More informationContents. Abstract...i. Committee Membership... iii. Foreword... vii. 1 Scope...1
ISBN 1-56238-584-4 Volume 25 Number 27 ISSN 0273-3099 Interference Testing in Clinical Chemistry; Approved Guideline Second Edition Robert J. McEnroe, PhD Mary F. Burritt, PhD Donald M. Powers, PhD Douglas
More informationNova Max Blood Glucose Monitor Owner s Guide
Nova Max Blood Glucose Monitor Owner s Guide Nova Biomedical 200 Prospect Street Waltham, MA 02454-9141 U.S.A. Telephone: 1-800-681-7390 Web site: www.novacares.com Made in the USA by Nova Biomedical Corporation
More informationThe Accuracy of Commercial Blood Uric Acid Meters on Blood Uric Acid Level Measurement
Article ID: WMC001778 2046-1690 The Accuracy of Commercial Blood Uric Acid Meters on Blood Uric Acid Level Measurement Corresponding Author: Dr. Tak S Ching, Assistant Professor, Graduate Institute of
More informationLab: Graphing Activities TOTTEN
Name: Class: Date Completed: Lab Minutes: Lab: Graphing Activities TOTTEN SCIENCE Introduction Graphing is used by scientists to display the data that is collected during a controlled experiment. A line
More informationBACKGROUND INFORMATION
BACKGROUND INFORMATION It is often important to measure the concentration of glucose in a solution. The so-called ISOTONIC drinks can be tested to see if they are in fact isotonic with the blood. You may
More informationfor patient monitoring
Thermo Scientific Indiko Reagents for Immunosuppressant Drug Testing Complete solutions for patient monitoring The cost-effective Thermo Scientific Indiko benchtop analyzer and bar-coded reagent is designed
More informationTest Positive True Positive False Positive. Test Negative False Negative True Negative. Figure 5-1: 2 x 2 Contingency Table
ANALYSIS OF DISCRT VARIABLS / 5 CHAPTR FIV ANALYSIS OF DISCRT VARIABLS Discrete variables are those which can only assume certain fixed values. xamples include outcome variables with results such as live
More informationStandardization, Calibration and Quality Control
Standardization, Calibration and Quality Control Ian Storie Flow cytometry has become an essential tool in the research and clinical diagnostic laboratory. The range of available flow-based diagnostic
More informationCourse outline. Code: MLS211 Title: Medical Biochemistry
Course outline Code: MLS211 Title: Medical Biochemistry Faculty of: Science, Health, Education and Engineering Teaching Session: Semester 2 Year: 2015 Course Coordinator: Dr Mark Holmes Tel: 5430 2844
More information